KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Return on Equity (2016 - 2025)

Gilead Sciences' Return on Equity history spans 17 years, with the latest figure at 0.4% for Q4 2025.

  • For Q4 2025, Return on Equity rose 38.0% year-over-year to 0.4%; the TTM value through Dec 2025 reached 0.4%, up 38.0%, while the annual FY2025 figure was 0.41%, 38.0% up from the prior year.
  • Return on Equity reached 0.4% in Q4 2025 per GILD's latest filing, up from 0.4% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.4% in Q4 2025 to a low of 0.01% in Q3 2024.
  • Average Return on Equity over 5 years is 0.22%, with a median of 0.25% recorded in 2023.
  • Peak YoY movement for Return on Equity: surged 40bps in 2021, then decreased -26bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.29% in 2021, then decreased by -26bps to 0.22% in 2022, then increased by 15bps to 0.25% in 2023, then crashed by -90bps to 0.03% in 2024, then soared by 1482bps to 0.4% in 2025.
  • Per Business Quant, the three most recent readings for GILD's Return on Equity are 0.4% (Q4 2025), 0.4% (Q3 2025), and 0.33% (Q2 2025).